176 related articles for article (PubMed ID: 1419646)
1. Comparison of plasma prolactin and CEA in monitoring patients with adenocarcinoma of colon and rectum.
Bhatavdekar JM; Patel DD; Giri DD; Karelia NH; Vora HH; Ghosh N; Shah NG; Trivedi SN; Balar DB
Br J Cancer; 1992 Nov; 66(5):977-80. PubMed ID: 1419646
[TBL] [Abstract][Full Text] [Related]
2. Correlation of the Serum Level of Carcinoembryonic Antigen and Prolactin with Different Stages of Colorectal Carcinoma According to Dukes' Staging.
Rahman MR; Sheikh SH; Lima IJ; Islam MR; Faisal M; Islam MS; Faruk MO; Jalal MT
Mymensingh Med J; 2016 Jan; 25(1):61-5. PubMed ID: 26931251
[TBL] [Abstract][Full Text] [Related]
3. Plasma prolactin in patients with colorectal cancer. Value in follow-up and as a prognosticator.
Patel DD; Bhatavdekar JM; Ghosh N; Vora HH; Karelia NH; Shah NG; Suthar TP; Balar DB; Trivedi CR
Cancer; 1994 Feb; 73(3):570-4. PubMed ID: 8299078
[TBL] [Abstract][Full Text] [Related]
4. Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer.
Fernandes LC; Kim SB; Saad SS; Matos D
World J Gastroenterol; 2006 Jun; 12(24):3891-4. PubMed ID: 16804977
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
Knychalski B; Lukieńczuk T
Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
[TBL] [Abstract][Full Text] [Related]
6. Prolactin and colorectal cancer: is there a connection?
Baert D; Matthys C; Gillardin JP; Lepoutre L; Thienpont L; Kaufman JM; Cuvelier C; De Vos M
Acta Gastroenterol Belg; 1998; 61(4):407-9. PubMed ID: 9923090
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated glycoprotein-72 serum levels complement carcinoembryonic antigen levels in monitoring patients with gastrointestinal carcinoma. A longitudinal study.
Guadagni F; Roselli M; Amato T; Cosimelli M; Mannella E; Perri P; Abbolito MR; Cavaliere R; Colcher D; Greiner JW
Cancer; 1991 Dec; 68(11):2443-50. PubMed ID: 1933781
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratins and carcinoembryonic antigen in diagnosis, staging and prognosis of colorectal adenocarcinoma.
Fernandes LC; Kim SB; Matos D
World J Gastroenterol; 2005 Feb; 11(5):645-8. PubMed ID: 15655814
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen and patterns of recurrence after curative resection of the colorectal cancer.
Park JY; Lee KH
Hepatogastroenterology; 2007; 54(79):1966-9. PubMed ID: 18251140
[TBL] [Abstract][Full Text] [Related]
10. Role of carcinoembryonic antigen as a marker for colorectal liver metastases.
Jones C; Badger SA; Epanomeratikis E; McKie LD; Diamond T; Taylor MA
Br J Biomed Sci; 2013; 70(2):47-50. PubMed ID: 23888604
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of carcinoembryonic antigen and carbohydrate antigen 19-9 in stage IV colorectal cancer patients after R0 resection.
Abe S; Kawai K; Ishihara S; Nozawa H; Hata K; Kiyomatsu T; Tanaka T; Watanabe T
J Surg Res; 2016 Oct; 205(2):384-392. PubMed ID: 27664887
[TBL] [Abstract][Full Text] [Related]
12. Value of carcinoembryonic antigen in the management of colorectal cancer.
Wang JY; Tang R; Chiang JM
Dis Colon Rectum; 1994 Mar; 37(3):272-7. PubMed ID: 8137675
[TBL] [Abstract][Full Text] [Related]
13. Improved tumour marker sensitivity in detecting colorectal liver metastases by combined type IV collagen and CEA measurement.
Nyström H; Tavelin B; Björklund M; Naredi P; Sund M
Tumour Biol; 2015 Dec; 36(12):9839-47. PubMed ID: 26162539
[TBL] [Abstract][Full Text] [Related]
14. Serum carcinoembryonic antigen monitoring after curative resection for colorectal cancer: clinical significance of the preoperative level.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg Oncol; 2009 Nov; 16(11):3087-93. PubMed ID: 19629600
[TBL] [Abstract][Full Text] [Related]
15. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
Veingerl B
Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of serum carcinoembryonic antigen monitoring in the follow-up of colorectal cancer patients with metastatic lymph nodes and a normal preoperative serum level.
Tobaruela E; Enriquez JM; Diez M; Camunas J; Muguerza J; Granell J
Int J Biol Markers; 1997; 12(1):18-21. PubMed ID: 9176713
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunolocalization of colorectal carcinoma. A correlation among RIL results, surgical findings, serum tumor marker levels and the presence of CEA and CA 19.9 in tumor tissue: the experience of the Hospital de la Santa Creu i Sant Pau.
Germá-Lluch JR; Alvarez I; Carrió I; Nogueras FM; Marcuello E; Estorch M; Berná L
Ann Oncol; 1991 Jun; 2(6):409-15. PubMed ID: 1768627
[TBL] [Abstract][Full Text] [Related]
18. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
[TBL] [Abstract][Full Text] [Related]
19. Postoperative CEA is a better prognostic marker than CA19-9, hCGβ or TATI after resection of colorectal liver metastases.
Peltonen R; Österlund P; Lempinen M; Nordin A; Stenman UH; Isoniemi H
Tumour Biol; 2018 Jan; 40(1):1010428317752944. PubMed ID: 29378497
[TBL] [Abstract][Full Text] [Related]
20. [Preoperative CEA: prognostic significance in colorectal carcinoma].
Turoldo A; Balani A; Scaramucci M; Pistan V; Roseano M; Liguori G
Tumori; 2003; 89(4 Suppl):95-7. PubMed ID: 12903559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
